MediWise

Medical Wireless Sensing Ltd. (MediWise) is a medtech company based in London, UK. MediWise combines microwave engineering with wireless sensing algorithms and the use of metamaterials. Founded by a team of entrepreneurial individuals and technical experts in 2010, MediWise is developing breakthrough solutions using three types of technologies: non-invasive glucose sensing (GlucoWise), MRI scanning (RadiWise) and cancer imaging (MammoWise).

Keysight E8361 vector network analyzer (up to 67 GHz); 3D printing facility; access to the Antennas Measurement Lab (AML) at Queen Mary University London and to clinical trial facilities for in-vivo animal trials at Northwick Park Institute for Medical Research (NPIMR).